The oncofetal gene Glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2

Hepatology

Volumn 46, Issue 5, 2007, Pages 1541-1547

  Morford, Lorri A ^a   Davis, Christina ^a   Jin, Lin ^a   Dobierzewska, Aneta ^a   Peterson, Martha L ^a   Spear, Brett T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DNA BINDING PROTEIN; GLYPICAN 3; HOMEODOMAIN PROTEIN; ZINC FINGER PROTEIN; ALPHA FETOPROTEIN REGULATOR 2; CARBON TETRACHLORIDE; MESSENGER RNA; ONCOFETAL ANTIGEN; UNCLASSIFIED DRUG; ZINC FINGER AND HOMEOBOXES 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; EMBRYONAL CARCINOMA; GENE; GENE CONTROL; GENE EXPRESSION; LIVER; LIVER CELL CARCINOMA; LIVER REGENERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENICS; ZHX2 GENE; ADULT; BAGG ALBINO MOUSE; CONTROLLED STUDY; FEMALE; FETUS LIVER; IN VITRO STUDY; MOUSE STRAIN; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ALPHA-FETOPROTEINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GLYPICANS; HOMEODOMAIN PROTEINS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MICE; MICE, INBRED STRAINS; RNA, MESSENGER; RNA, UNTRANSLATED;

EID: 36348954344     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21825     Document Type: Article

References (36)

1. De Cat B, David G. Developmental roles of the glypicans. Semin Cell Dev Biol 2001;12:117-125.
2. Filmus J. Glypicans in growth control and cancer. Glycobiology 2001;11:R19-R23.
3. Song HH, Filmus J. The role of glypicans in mammalian development. Biochim Biophys Acta 2002;1573:241-246.
4. Filmus J, Selleck SB. Glypicans: proteoglycans with a surprise. J Clin Invest 2001;108:497-501.
5. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 1996;12:241-247.
6. Lin H, Huber R, Schlessinger D, Morin PJ. Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res 1999;59:807-810.
7. Murthy SS, Shen T, De Rienzo A, Lee WC, Ferriola PC, Jhanwar SC, et al. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene 2000;19:410-416.
8. Xiang YY, Ladeda V, Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene 2001;20:7408-7412.
9. Hsu HC, Cheng W, Lai PL. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res 1997;57:5179-5184.
10. Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006;131:1758-1767.
11. Wang XY, Degos F, Dubois S, Tessiore S, Allegretta M, Guttmann RD, et al. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol 2006;37:1435-1441.
12. Abelev GI, Eraiser TL. Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin Cancer Biol 1999;9:95-107.
13. Belayew A, Tilghman SM. Genetic analysis of α-fetoprotein synthesis in mice. Mol Cell Biol 1982;2:1427-1435.
14. Spear BT. Alpha-fetoprotein gene regulation: lessons from transgenic mice. Semin Cancer Biol 1999;9:109-116.
15. Pachnis V, Brannan CI, Tilghman SM. The structure and expression of a novel gene activated early in mouse embryogenesis. EMBO J 1988;7:673-681.
16. Ariel I, Miao HQ, Ji XR, Schneider T, Roll D, de Groot N, et al. Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol Pathol 1998;51:21-25.
17. Olsson M, Lindahl G, Roushlahti E. Genetic control of alpha-fetoprotein synthesis in the mouse. J Exp Med 1977;145:819-830.
18. Pachnis V, Belayew A, Tilghman SM. Locus unlinked to α-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci U S A 1984;81:5523-5527.
19. Perincheri S, Dingle RW, Peterson ML, Spear BT. Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB/cJ mice is due to a retrovirus insertion in the Zhx2 gene. Proc Natl Acad Sci U S A 2005;102:396-401.
20. Spear BT, Jin L, Ramasamy S, Dobierzewska A. Transcriptional control in the mammalian liver: liver development, perinatal repression, and zonal gene regulation. Cell Mol Life Sci 2006;63:2922-2938.
21. Lu Z, Zhang M, Bi J, Xu F, Hu S, Wen J. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma. Am J Clin Pathol 2006;125:740-746.
22. Spear BT, Ellis AW. Endogenous and transfected mouse alpha-fetoprotein genes in undifferentiated F9 cells are activated in transient heterokaryons. Somat Cell Mol Genet 1995;21:19-31.
23. Spear BT. Mouse α-fetoprotein gene 5′ regulatory elements are required for postnatal regulation by raf and Rif. Mol Cell Biol 1994;14:6497-6505.
24. Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression postnatal liver development and regeneration. Genes Dev 1996;10:245-260.
25. Jin DK, Vacher J, Feuerman MH. α-Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration. Proc Natl Acad Sci U S A 1998;95:8767-8772.
26. Grover A, Oshima R, Adamson E. Epithelial layer formation in differentiating aggregates of F9 embryonal carcinoma cells. J Cell Biol 1983;96:1690-1696.
27. Hogan BLM, Barlow DP, Tilly R. F9 teratocarcinoma cells as a model for the differentiation of parietal and visceral endoderm in the mouse embryo. Cancer Surv 1983;2:115-140.
28. Hu S, Zhang M, Lv Z, Bi J, Dong Y, Wen J. Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis. Neoplasma 2007;54:207-211.
29. Jin DK, Feuerman MH. Genetic mapping of Afr2 (Rif): regulator of gene expression in liver regeneration. Mamm Genome 1998;9:256-258.
30. Grozdanov PN, Yovchev MI, Dabeva MD. The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells. Lab Invest 2006;86:1272-1284.
31. Scott RW, Vogt TF, Croke ME, Tilghman SM. Tissue-specific activation of a cloned α-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line. Nature 1984;310:562-567.
32. Ota S, Hishinuma M, Yamauchi N, Goto A, Morikawa T, Fujimura T, et al. Oncofetal protein glypican-3 in testicular germ-cell tumor. Virchows Arch 2006;449:308-314.
33. Zynger DL, Dimov ND, Luan C, Teh BT, Yang XJ. Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol 2006;30:1570-1575.
34. Kawata H, Yamada D, Shou Z, Mizutani T, Miyamoto K. The mouse zinc-fingers and homeoboxes (ZHX) family; ZHX2 forms a heterdimer with ZHX3. Gene 2003;323:133-140.
35. Peyton DK, Huang M-C, Giglia MA, Hughes NK, Spear BT. The alpha-fetoprotein promoter is the target of Afr1-mediated postnatal repression. Genomics 2000;63:173-180.
36. Vacher J, Camper SA, Krumlauf R, Compton RS, Tilghman SM. raf regulates the postnatal repression of the mouse α-fetoprotein gene at the posttranscriptional level. Mol Cell Biol 1992;12:856-864.